Schonfeld Strategic Advisors »

Design Therapeutics shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Design Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Design Therapeutics held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Design Therapeutics by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2023-06-30 $89k 14k 6.30
2023-03-31 $77k 13k 5.77

More positions owned by Schonfeld Strategic Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Ishares Ethereum Tr SHS (ETHA)
Fidelity Wise Origin Bitcoin SHS (FBTC)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ark 21shares Bitcoin Etf Shs Ben Int (ARKB)
Broadcom (AVGO)
Ishares Tr Core S&p500 Etf (IVV)
Alibaba Group Hldg Sponsored Ads (BABA)
Union Pacific Corporation (UNP)
Tesla Motors (TSLA)
Marvell Technology (MRVL)
Boston Scientific Corporation (BSX)

View all positions for Schonfeld Strategic Advisors

Top funds holding Design Therapeutics

Sr One Capital Management
Logos Global Management
Point72 Asset Management
BlackRock
Frazier Life Sciences Management
Tang Capital Management
Baker Bros. Advisors
Almitas Capital
Vanguard Group
Driehaus Capital Management
Kynam Capital Management
FMR
Geode Capital Management
State Street Corporation
Acadian Asset Management

View all funds holding Design Therapeutics